Cytotoxicity of 2A fractions: 2AFH, 2AFM and 2AFU against HeLa and MRC5-SV2 cells

2A FractionsCell lineET (h)Cell viability (negative control normalised to 100%)IC50 (μg/mL)
10 μg/mL50 μg/mL100 μg/mL200 μg/mL
2AFHHeLa4872.3 ± 2.5***48.7 ± 3.0***39.0 ± 4.9***32.7 ± 4.7***59.4 ± 11.1
72104.6 ± 3.359.6 ± 2.8***40.3 ± 3.6***31.2 ± 1.2***84.0 ± 6.1
MRC5-SV24880.4 ± 5.1*55.3 ± 4.3***42.1 ± 3.6***33.3 ± 4.0***63.2 ± 12.4
72104.3 ± 3.949.4 ± 6.6***30.3 ± 5.3***21.5 ± 3.5***60.4 ± 11.8
2AFMHeLa48120.6 ± 4.3120.8 ± 6.8109.0 ± 2.448.2 ± 7.5***> 700
72106.7 ± 5.8111.4 ± 2.078.9 ± 6.527.5 ± 3.0***235.0 ± 17.8
MRC5-SV248105.0 ± 3.5115.4 ± 3.798.9 ± 5.446.6 ± 11.8***> 500
72136.3 ± 15.2112.8 ± 1.1100.5 ± 4.263.0 ± 3.1***> 600
2AFUHeLa4874.8 ± 2.0***60.9 ± 2.7***50.1 ± 4.1***41.3 ± 4.3***99.0 ± 14.2
7279.6 ± 4.6**63.0 ± 3.4***49.5 ± 3.3***30.2 ± 3.0***87.0 ± 10.7
MRC5-SV24874.3 ± 3.1***62.1 ± 2.7***54.5 ± 1.9***43.8 ± 0.9***109.0 ± 12.2
72106.9 ± 4.476.7 ± 1.7*56.5 ± 4.1***38.5 ± 4.6***146.0 ± 17.5

* P < 0.05, ** P < 0.01, and *** P < 0.001 indicate a significant difference between the cell viability of treated cells and the cell viability of untreated cells of the negative control wells. ET: exposure time in hours